Preferred Label : benzyl compounds;
MeSH definition : Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R.;
MeSH synonym : compounds, benzyl;
MeSH annotation : do not confuse with benzil; DF: BENZYL CPDS;
Is substance : O;
Origin ID : D001593;
UMLS CUI : C0005103;
Allowable qualifiers
Record concept(s)
Related MeSH Supplementary Concept(s)
- (N-(4-(2,2,2-trifluoroethyl) benzylidene) (7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)
meth-anamine) [MeSH Supplementary Concept]
- BB 1101 [MeSH Supplementary Concept]
- BOS-102 [MeSH Supplementary Concept]
- IBR120 [MeSH Supplementary Concept]
- LDD2269 [MeSH Supplementary Concept]
- MI-1851 [MeSH Supplementary Concept]
- MP407 [MeSH Supplementary Concept]
- ONC206 [MeSH Supplementary Concept]
- ONC212 [MeSH Supplementary Concept]
- RG 6866 [MeSH Supplementary Concept]
- TZ6019 [MeSH Supplementary Concept]
Semantic type(s)
Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R.
https://www.ema.europa.eu/en/medicines/human/EPAR/mayzent
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
siponimod
siponimod
drug approval
europe
adult
multiple sclerosis, chronic progressive
siponimod
administration, oral
Sphingosine-1-Phosphate receptors
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
Mayzent
Product containing only siponimod in oral dose form (medicinal product form)
receptors, lysosphingolipid
azetidines
benzyl compounds
azetidines
benzyl compounds
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
---
https://www.has-sante.fr/jcms/p_3196679/fr/mayzent
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
siponimod
siponimod
siponimod
Sphingosine-1-Phosphate receptors
adult
multiple sclerosis, secondary progressive
multiple sclerosis, chronic progressive
administration, oral
Product containing only siponimod in oral dose form (medicinal product form)
Mayzent
receptors, lysosphingolipid
azetidines
benzyl compounds
azetidines
benzyl compounds
---
http://www.inrs.fr/accueil/produits/bdd/doc/fichetox.html?refINRS=FT%2090
France
French
benzyl compounds
benzyl compounds
benzyl compounds
benzyl compounds
benzyl compounds
occupational exposure
occupational diseases
reference values
benzyl chloride
guidelines
toxicological data sheet
---